Computed tomographic measurement of local cerebral blood flow by xenon enhancement

Apparent brain temperature imaging with multi-voxel proton magnetic resonance spectroscopy compared with cerebral blood flow and metabolism imaging on positron emission tomography in patients with unilateral chronic major cerebral artery steno-occlusive disease

PURPOSE

The purpose of the present study was to determine whether apparent brain temperature imaging using multi-voxel proton magnetic resonance (MR) spectroscopy correlates with cerebral blood flow (CBF) and metabolism imaging in the deep white matter of patients with unilateral chronic major cerebral artery steno-occlusive disease.

METHODS

Apparent brain temperature and CBF and metabolism imaging were measured using proton MR spectroscopy and ¹⁵O-positron emission tomography (PET), respectively, in 35 patients. A set of regions of interest (ROIs) of 5 × 5 voxels was placed on an MR image so that the voxel row at each edge was located in the deep white matter of the centrum semiovale in each cerebral hemisphere. PET images were co-registered with MR images with these ROIs and were re-sliced automatically using image analysis software.

RESULTS

In 175 voxel pairs located in the deep white matter, the brain temperature difference (affected hemisphere - contralateral hemisphere: ΔBT) was correlated with cerebral blood volume (CBV) (r = 0.570) and oxygen extraction fraction (OEF) ratios (affected hemisphere/contralateral hemisphere) (r = 0.641). We excluded voxels that contained ischemic lesions or cerebrospinal fluid and calculated the mean values of voxel pairs in each patient. The mean ΔBT was correlated with the mean CBF (r = - 0.376), mean CBV (r = 0.702), and mean OEF ratio (r = 0.774).

CONCLUSIONS

Apparent brain temperature imaging using multi-voxel proton MR spectroscopy was correlated with CBF and metabolism imaging in the deep white matter of patients with unilateral major cerebral artery steno-occlusive disease.

Physiologic Effects of Xenon in Xenon-CT Cerebral Blood Flow Studies on Comatose Patients

Despite more than 30 years of clinical use, questions remain about the safety of xenon gas in Xenon-CT cerebral blood flow (XeCTCBF) studies. In particular, xenon's effect on brain oxygen (PbtO2) in comatose patients is not well defined. Our objective was to assess the effect of a 4.5-min inhalation of 28 % stable xenon on several physiologic variables, including intracranial pressure (ICP), cerebral perfusion pressure (CPP), and PbtO2 in comatose patients (Glasgow Coma Scale [GCS] ≤ 8). Thirty-seven comatose patients who underwent 73 XeCTCBF studies were identified retrospectively from a prospective observational database. Changes in MAP, HR, SaO2, EtCO2, ICP, CPP, and PbtO2 measured at the start of xenon administration and every minute for 5 min thereafter were assessed. The maximum change in each variable also was determined for each scan to tabulate clinically relevant changes. Statistically, but not clinically significant changes in MAP, HR, and EtCO2 were seen. Xenon had no effect on ICP, and a small, but clinically insignificant decrease in CPP and PbtO2, was observed. There was a varied response to xenon in most measured variables. Clinically significant changes in each were infrequent, and readily reversed with the cessation of the gas. We conclude that xenon does not appear to have a clinically significant effect on ICP, CPP, and PbtO2 and so appears safe to evaluate cerebral blood flow in comatose patients.

Changes in Cerebral Blood Flow from the Acute to the Chronic Phase of Severe Head Injury

We studied cerebral blood flow (CBF) in the transition from the acute to the chronic phase of severe head injury in order to determine patterns of change in relation to neurological outcome. We measured CBF with stable xenon-enhanced computed tomography (Xe-CT) in 20 consecutive patients at 1, 2, 3, 4, and 6 weeks after severe head injury, and analyzed the relation between the pattern of change in CBF and neurological outcome at 6 months after injury. CBF values were significantly lower in the brain-injured patients than in 14 healthy volunteers, except at 3 weeks after injury, when CBF increased in the patients to a value that did not differ significantly from that in the normal volunteers. We therefore focused on the change in CBF at 3 weeks after injury. We separated the 20 brain-injured patients into two subgroups, of which the first (subgroup A) consisted of nine patients whose CBF had returned to normal by week 3 post-injury, while the second (subgroup B) consisted of 11 patients whose CBF was subnormal at week 3 post-injury. CBF was significantly higher in subgroup A than in subgroup B at 2 weeks post-injury (p < 0.05). CBF in subgroup B remained significantly lower than that in subgroup A throughout the study period. At 6 months post-injury, subgroup A had a significantly better neurological outcome than did subgroup B (p < 0.05). We conclude that patients whose CBF returns to normal at 2-3 weeks following severe traumatic brain injury after being abnormally low in the acute phase of injury can be expected to achieve a good neurological outcome.

Alteration of rCBF in skull base lesions

Cerebral functional imaging methods provide complementary information on brain function and large vessels regulatory controls which are compromised in cranial base lesions. The presence of a skull base tumor can alter regional cerebral blood flow (rCBF) in adjacent and remote brain tissue. This report presents the results of 104 CBF studies in 66 patients with skull base lesions (aged 17-75 years). The lesions included 36 meningiomas, 21 neurinomas and 9 other tumors. Regional CBF in tumor and brain tissue was measured prior to treatment using stable xenon enhanced computed tomography (Xenon(/T). For the quantitative analysis, regions of interest were delineated on tumor regions, cerebral and cerebellar hemispheres including peritumoral regions. In order to assess the remote effect of cerebellopontine angle (CPA) tumors, the brainstem, cerebellar, and cerebral blood flow were measured in 26 cases. The average brainstem CBF for patients with good outcome was higher than the average brainstem CBF for patients with poor outcome. This indicates that CBF studies in posterior fossa can be useful in predicting the prognosis of CPA tumor patients. We report a series of 16 patients with cavernous sinus tumors in whom the internal carotid artery was affected by the tumor. In nearly all cases Xenon/CT CBF studies with acetazolamide test showed no significant difference in hemispheric perfusion and a sufficient cerebrovascular reserve capacity. Interhemispheric asymmetry was present only in one patient. These results possibly indicate that i.v. administration of acetazolamide might contribute in selecting patients with higher risk for ischemic deficits after cavernous sinus surgery. Skull base meningiomas showed very high blood flow with a wide range. Local CBF in the peripheral region of meningiomas was higher than in the central region. Blood flow values in the peritumoral areas are about 30% lower than those of the ipsilateral hemisphere. In individual cases, blood flow values in the peritumoral low-density area on CT were extremely low. It is concluded that CBF studies in skull base tumors are valuable in treatment planning. Xenon/CT can be useful additional diagnostic procedure in the evaluation of skull base surgery candidates.

Discrepancy of xenon concentrations between end-tidal and blood collection methods in xenon-enhanced computed tomographic measurements of cerebral blood flow

Using xenon-enhanced computed tomography for the study of cerebral blood flow, simultaneous measurements of end-tidal and arterial blood xenon concentrations using the blood collection method were performed to investigate the validity of substituting the end-tidal for the arterial blood xenon concentration. Simultaneous measurement by both methods was performed 68 times in 27 patients. There was no statistical correlation between the arterial blood accumulation rate constant obtained by arterial blood and end-tidal samples, nor between the arterial blood saturation value obtained by the two methods, even when correction was made for age. In brain tissue, all parameters calculated using the end-tidal concentration were lower than those using arterial blood. We therefore suggest that cerebral blood flow values calculated using end-tidal xenon concentration are useful only for qualitative cerebral blood flow mapping, and not applicable to absolute values of cerebral blood flow.

EEG changes during five minutes of inhalation of a 33% xenon-O2 mixture

The effects on the EEG of inhalation of a 33% Xenon O2 mixture over a period of 5 minutes were studied in 18 human volunteers. This dosage is similar to that used in xenon CT studies. In 4 subjects no EEG changes were observed during the study. In the 14 other subjects, EEG variations were detected, the most prominent of which was an increase in beta power. No change was observed in theta and delta power. These findings seem to support an early induction (excitation) phase of anaesthetics. All changes disappeared rapidly following the termination of xenon inhalation. The effects reported are minimal and should not impair the clinical value of CBF measurements using the xenon CT method.

Stable-xenon-CT: effects of xenon inhalation on EEG and cardio-respiratory parameters in the human

The effects of inhalation of a 33% Xenon-O2 mixture over a period of 5 minutes on EEG and cardio-respiratory parameters were studied in 18 human volunteers. This dosage is similar to that used clinically in Xenon-CT studies. In 4 cases no EEG power change was observed during the study. In the 14 other subjects EEG variations were seen. The most prominent change was an increase in beta EEG power. No change was observed in theta and delta EEG power. The findings seem to correlate with the early induction (excitation) phase of an anaesthetic. Hyperventilation was observed before the study and increased during the Xenon inhalation. Blood pressure remained stable while the heart rate tended to decrease a little. All these changes disappeared rapidly following the termination of the Xenon inhalation. The effects are minimal and should not reduce the clinical value of CBF measurement using the Xenon-CT method.

Hydrogen clearance method for determining local cerebral blood flow. II. Effect of heterogeneity in cerebral blood flow

The time course of hydrogen uptake and washout was followed simultaneously in extracranial arterial blood, cortex, subcortical white matter, and caudate nucleus of the cat brain to study intercompartmental hydrogen concentration differences. A clear delay of 1-2 min was seen between the onsets of concentration increase in arterial blood and low-flow brain tissues. Equilibration time was dependent on local CBF and varied between 3 and 34 min. Hydrogen was not cleared simultaneously from the regions under detection. This led to considerable concentration differences within the cerebral tissue during washin and washout phases. Analysis of the clearance curves revealed that secondary equilibration occurs during washout. Hydrogen concentration in the external carotid artery was not a reliable reflection of tracer input in the brain tissues. The consequences of these observations for other techniques of CBF measurement using less diffusive gases and external detection are discussed.

Xenon contrast CT-CBF measurements in parkinsonism and normal aging

Local cerebral blood flow (LCBF) and local tissue:blood partition, coefficient (L lambda) values were measured during CT scanning while patients with different types of Parkinson's syndrome (N = 14) inhaled a contrast mixture of 35-37 per cent stable xenon gas in oxygen. Single-compartment analysis fitted to infinity was used to calculate L lambda and LCBF values. Results were compared with results from normal age-matched volunteers (N = 24). Mean hemispheric (p less than 0.05) and subcortical (p less than 0.05) gray matter LCBF values were reduced in idiopathic Parkinson's disease (N = 11), compared to values from age-matched normals. Regionally, LCBF reductions included frontal (p less than 0.001), parietal cortex (p less than 0.05), caudate (p less than 0.05), lentiform nuclei (p less than 0.001) and thalamus (p less than 0.05) reductions. L lambda values were normal. Unilateral tremor and/or rigidity correlated directly with reduced LCBF in contralateral lentiform (p less than 0.01) and caudate (p less than 0.01) nuclei. In postencephalitic Parkinsonism (N = 1) LCBF reductions were diffuse, with normal L lambda values. In the akinetic form of Parkinsonism (N = 1) associated with lacunar infarcts, LCBF and L lambda reductions were patchy. In Parkinsonism following carbon monoxide poisoning (N = 1), LCBF values of gray and white matter were diffusely reduced and L lambda values were reduced in both pallidal regions. When dementia was present together with Parkinsonism (N = 3), LCBF reductions were more diffuse and severe. Dopaminergic deficiency correlated directly with reduced LCBF values, reflecting the severity of Parkinsonism.

Effects of xenon and krypton on regional cerebral blood flow in the rat

The effects of high inspired concentrations of xenon and krypton on regional CBF (rCBF) were assessed in the rat using [14C]iodoantipyrine and quantitative autoradiography. Inhalation of 80% xenon for 1 or 2 min and inhalation of 40% xenon for 2 min were found to have significant effects on rCBF, including average increases of 75-96% in cerebral neocortical regions. Inhalation of 40% xenon for 1 min and of 80% krypton for 2 min had no significant effect on rCBF in most brain regions studied. If xenon inhalation produces effects on rCBF in humans similar to those observed in the rat, such effects could be an important source of error in xenon computed tomography rCBF studies.

Dynamic computed tomography of the brain

Dynamic computed tomography (CT) scanning was performed on five normal subjects, 38 patients with cerebrovascular disorder, and 20 patients with brain tumours. It consisted of performing six rapid sequential scans after intravenous bolus injection of iodinated contrast medium. By gamma variate fit technique, five features (corrected first moment, area, peak, time to peak, and per cent terminal height) were obtained from a time-density curve in a region of interest. We compared these features in one side of the brain with those in the corresponding contralateral side and tried to get information about cerebral perfusion. These results showed that by this technique we are able to detect arterial occlusions or Moya moya diseases non-invasively and know earlier and more clearly the re-establishment of circulation in the occluded arteries and of extravasation of contrast medium in ischaemic regions than by conventional CT scanning. In arteriovenous malformations, serial images of dynamic CT scanning demonstrated the anatomical details of the nidus, and the afferent and efferent vessels. We can also identify an exact extent of tumoral invasion of the brain in patients with malignant brain tumor.

Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease

Cerebral blood flow mapping with the xenon-enhanced/CT method has become a useful clinical tool in the management of patients with occlusive cerebral vascular disease. Studies involving 4-5 minutes of inhaling a xenon/oxygen mixture (less than or equal to 35%) can now be performed routinely with acceptable patient tolerance and compliance. Four cases with acute and chronic ischemic injuries are reported here to illustrate the manner in which this method has been used to characterize flow pattern in such patients and the relevance of this flow information to clinical patient management.